Ra Medical Systems, Inc.
SEC CIK 1716621 · rmed · last insider filing 2026-03-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Colombatto Martin J | Director | filed 2018 - 2026 |
| Jenkins David A | Director · Executive Chairman of Board | filed 2023 - 2026 |
| Caruso James Joseph | Director | filed 2023 - 2026 |
| Arno Andrew | Director | filed 2024 - 2026 |
| Francis, John P. | Director | filed 2024 - 2024 |
| Meline Susanne | Director | filed 2021 - 2023 |
| Mcguire Jonathan Will | Director · Chief Executive Officer | filed 2020 - 2023 |
| Mejia Richard Jr | Director | filed 2018 - 2021 |
| Stafslien Joan | Director | filed 2020 - 2021 |
| Enquist William R | Director | filed 2018 - 2021 |
| Saad Mark E | Director | filed 2018 - 2021 |
| Burstein Melissa | Director · Executive Vice President | filed 2018 - 2020 |
| Irwin Dean | Director · See Remarks | filed 2018 - 2020 |
| Buchbinder Maurice | Director | filed 2018 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Anderson Philip J | Chief Financial Officer | filed 2025 - 2026 |
| Jacques Marie-Claude | Chief Commercial Officer | filed 2024 - 2025 |
| Thomassen Margrit | Interim CFO and Secretary | filed 2024 - 2024 |
| Passey Steven K | Chief Financial Officer | filed 2023 - 2023 |
| Conn Brian | Chief Financial Officer | filed 2022 - 2022 |
| Jackson Andrew C. | CFO & Secretary | filed 2018 - 2022 |
| Kraws Jeffrey J | Co-President | filed 2018 - 2020 |
| Horwood Daniel | General Counsel | filed 2018 - 2020 |
| Fogarty Thomas G | See Remarks | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.